Hostname: page-component-68c7f8b79f-wfgm8 Total loading time: 0 Render date: 2025-12-23T03:55:00.590Z Has data issue: false hasContentIssue false

Leveraging de-implementation science to promote infection prevention and stewardship: a roadmap and practical examples (Part II of II)

Published online by Cambridge University Press:  10 September 2025

Westyn Branch-Elliman*
Affiliation:
Department of Medicine, Section of Infectious Diseases, Greater Los Angeles VA Healthcare System, Los Angeles, CA, USA Center for the Study of Healthcare Innovation, Implementation, and Policy, Greater Los Angeles VA Healthcare System, Los Angeles, CA, USA Department of Medicine, Section of Infectious Diseases, UCLA David Geffen School of Medicine, Los Angeles, CA, USA
Samira Reyes Dassum
Affiliation:
Division of Infectious Disease, Department of Medicine, Roger Williams Medical Center, Providence, RI, USA
Stephanie Stroever
Affiliation:
Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, USA
Owen Albin
Affiliation:
Department of Internal Medicine, Division of Infectious Diseases, University of Michigan Medical School, Ann Arbor, MI, USA
Lynne Batshon
Affiliation:
Director of Policy & Practice, Society for Healthcare Epidemiology of America, Arlington, VA, USA
Sandra Castejon-Ramirez
Affiliation:
St. Jude Children’s Research Hospital, University of Tennessee Health Science Center, Memphis, TN, USA
Vincent Chi-Chung Cheng
Affiliation:
Queen Mary Hospital, Hong Kong West Cluster, Hong Kong Special Administrative Region, Pokfulam, China
Nkechi Emetuche
Affiliation:
Senior Program Coordinator, Society for Healthcare Epidemiology of America, Arlington, VA, USA
Rupak Datta
Affiliation:
Veterans Affairs Connecticut Healthcare System and Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, USA
Mini Kamboj
Affiliation:
Department of Medicine, Section of Infectious Diseases, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA
Sarah L. Krein
Affiliation:
Department of Medicine, Ann Arbor VA Healthcare System and University of Michigan School of Medicine, Ann Arbor, MI, USA
Milner Staub
Affiliation:
Department of Medicine, Section of Infectious Diseases, Vanderbilt University Medical Center and VA Tennessee Valley Healthcare System, Nashville, TN, USA
Barry Rittmann
Affiliation:
Department of Internal Medicine, Division of Infectious Diseases, Virginia Commonwealth University Health Systems, Richmond, VA, USA
Felicia Scaggs Huang
Affiliation:
Division of Infectious Diseases, Cincinnati Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA
Pranavi Sreeramoju
Affiliation:
Independent Scholar
Geehan Suleyman
Affiliation:
Division of Infectious Diseases, Department of Medicine, Henry Ford Health, Detroit, MI, USA Infection Prevention and Control and Antimicrobial Stewardship, Henry Ford Health, Detroit, MI, USA Michigan State University School of Medicine, Lansing, MI, USA Wayne State University School of Medicine, Detroit, MI, USA
Joseph Y. Ting
Affiliation:
Department of Pediatrics, University of Alberta, Edmonton, AB, Canada
Lucy S. Witt
Affiliation:
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
Matthew J. Ziegler
Affiliation:
Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Jennie H. Kwon
Affiliation:
Washington University School of Medicine, Department of Medicine, St. Louis, MO, USA
*
Corresponding author: Westyn Branch-Elliman; Email: wbranchelliman@mednet.ucla.edu
Rights & Permissions [Opens in a new window]

Abstract

De-implementation of established practices is a common challenge in infection prevention and antimicrobial stewardship and a necessary part of the life cycle of healthcare quality improvement programs. Promoting de-implementation of ineffective antimicrobial use and increasingly of low-value diagnostic testing are cornerstones of stewardship practice. Principles of de-implementation science and the interplay of implementation and de-implementation are discussed in part I of this Society for Healthcare Epidemiology of America White Paper Series.In this second part of the series, we discuss a process for applying principles of de-implementation science in infection prevention and stewardship and then review some real-world examples and case studies, including a national blood culture shortage, contact precautions, and surgical and dental prophylaxis. We use these examples to demonstrate how barriers and facilitators can be mapped to evidence-informed implementation/de-implementation strategies to promote efforts to reduce low-value, ineffective, or out-of-date practices. These real-world examples highlight the need for infection prevention and stewardship programs to adapt to changing evidence, contexts, and conditions. Although barriers to practice change are often a bit different, de-implementation can sometimes be thought of as the implementation of a new program—but the new program aims to stop rather than start doing something.

As the saying goes, sometimes less really is more. Medicine and public health have a strong action bias and a strong aversion to risk and uncertainty. Although our best intentions may point us to implementing more interventions, often, the best medicine instead dictates that we do less, or nothing at all. Leveraging principles of de-implementation science can help move healthcare in the right direction when interventions are low-value, ineffective, or no longer needed.

Information

Type
SHEA White Paper
Creative Commons
Creative Common License - CCCreative Common License - BY
This is a work of the US Government and is not subject to copyright protection within the United States. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America.
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© Department of Veterans Affairs, 2025

Introduction

De-implementation of established practices is a common challenge in infection prevention and antimicrobial stewardship and a necessary part of the life cycle of healthcare quality improvement programs. Promoting de-implementation of ineffective antimicrobial use practices, and increasingly of low-value diagnostic testing, are cornerstones of stewardship practice. Principles of de-implementation science and the interplay of implementation and de-implementation are discussed in Part I of this Society for Healthcare Epidemiology of America (SHEA) White Paper Series. Reference Branch-Elliman, Chambers and Albin1 In this second part of the series, we discuss a process for applying principles of de-implementation science in infection prevention and stewardship and then review several real-world examples and case studies.

An evidence-based process for de-implementation

De-implementation efforts typically focus on interventions that fall into one of several categories of evience basis: those that are ineffective and wasteful but not harmful, those that are harmful and actively contraindicated, often with associated “medical reversals,” those with a mixed or conflicting evidence base, and those that are untested and/or have limited evidence to support use. Reference Norton and Chambers2 Norton and Chambers highlight that distinguishing the evidence underpinning the intervention being targeted as part of the de-implementation process is important because each has different barriers to de-implementation and different actions to remediate negative outcomes. These barriers and actions are best addressed through different types of tailored implementation/de-implementation strategies. Reference Norton and Chambers2

De-implementation of programs can involve removing, replacing, reducing, or restricting the delivery of a low-value or untested interventions; examples of each one of these different types of de-implementation approaches exist within infection prevention and stewardship. Reference Norton and Chambers2,Reference Norton, Kennedy and Chambers3 For example, and discussed in more detail below, contact-based precautions have been replaced in many settings with newer, more effective strategies, such as decolonization protocols. Many antimicrobial stewardship and diagnostic stewardship interventions do not aim to stop the use of antibiotics or testing entirely, but rather to restrict or reduce their use to improve yield and minimize harms. Different programmatic aims (eg, complete removal, replacement, or reduction/restriction) imply different implementation strategies and approaches. Reference Powell, Beidas and Lewis4Reference Waltz, Powell, Fernández, Abadie and Damschroder7

Prior to initiating a de-implementation project, formative work, often manifested as qualitative interviews combined with the collection of quantitative data, may be helpful to guide the process of designing the de-implementation plan. First, data about existing practices, including volume and patterns of use, should be collected. This may include a combination of qualitative input as well as quantitative data from healthcare data systems to establish baseline use and ultimately to provide a benchmark for evaluating the impact of the de-implementation effort. Quantification of the degree and scope of the practice that requires de-implementation efforts can also be used to guide the implementation/de-implementation strategies deployed as well as the targets of these strategies (eg, is this a systemwide problem? A single provider problem? A unit problem?). Answers to these questions will guide overall de-implementation initiative efforts.

After gathering some information about the scope of the problem and establishing baseline use, collecting input from those impacted by the change about implementation outcomes, particularly about existing processes and embedded workflows that facilitate an ongoing low-value practice and the reasons why providers continue to pursue that low-value practice, may be helpful for identifying facilitators and barriers to discontinuation. These formative evaluations can also shed light on how deeply engrained a practice is, which has implications for how difficult a de-implementation initative is likely to be. This, in turn, can be used to guide the complexity and design of the bundle of de-implementation strategies. Engagement of facility stakeholders and leadership to learn about institutional priorities and how these can be leveraged to support the de-implementation project is also an important strategy for success. As discussed in more detail in Part I of this series, Reference Branch-Elliman, Chambers and Albin1 when considering de-implementation, particular attention should be given to liability concerns, action bias, and embedded processes that continue to support a given practice. Reference Norton and Chambers2 Uncertainty can also be a major barrier to de-implementation that needs to be considered prior to embarking upon a program focused on discontinuing or reducing low-value care. Reference Eva, Simone and Gert8

After barriers (eg, knowledge gaps, existing order sets with out-of-date recommendations, posters or other educational materials present in the medical center that are no longer relevant) and facilitators (eg, engaged and respected opinion leaders supporting the project, facility leadership support, desire to improve efficiency and reduce costs, desire to improve outcomes, policy change) are identified, these barriers and facilitators can be mapped to implementation strategies to create an evidence-informed de-implementation bundle to support the effort to discontinue the low-value practice. After the de-implementation initiative has been launched, ongoing evaluations should focus on the degree to which practices have changed in response to these efforts. Ongoing adaptations based on lessons learned during the de-implementation initiative may be needed to achieve the desired level of success. A process map for considering de-implementation is presented in Figure 1, and several case studies of leveraging de-implementation in stewardship and infection prevention follow.

Figure 1. Practical application of de-implementation science principles to support effective removal of low-value care.

Figure 2. De-implementation mapping process applied to reducing unnecessary blood culture orders.

Diagnostic stewardship

Diagnostic stewardship aims to optimize testing utilization with the downstream impacts of reducing unnecessary testing, improving diagnostic accuracy, and reducing unnecessary treatments; in other words, the field focuses on the reduction or restriction of low-value testing. Diagnostic stewardship iniatives face several barriers: (1) many providers are driven to order tests due to concerns about medical liability; (2) once a test result is available, even if the test was not indicated, it is difficult for providers to dismiss the result and not act upon it; and (3) many providers do not have a strong intuitive sense of pretest probability prior to a test, positive and negative predictive value, or how much a clinical test should move posttest probability of disease. Reference Morgan, Malani and Diekema9,Reference Morgan, Pineles and Owczarzak10 Existing order sets and bundles embedded into electronic health records (EHRs) may also create obstacles to de-implementation. Knowledge gaps about indications for treatment given a test can also drive inappropriate testing practices. Facilitators supporting de-implementation can be more difficult to identify but can include supply challenges and other external pressures to support change or changes in the availability of testing.

Changing the culture of culturing

Leveraging the blood culture bottle shortage as part of a bundle to improve use

Although indicated in many clinical scenarios, blood cultures to rule out bacteremia are well known to be overutilized, with up to 90% of blood cultures in hospitalized patients yielding no growth. Reference Grace, Lieberman, Pierce and Littenberg11,Reference Wilson12 This creates a need for implementation/de-implementation strategies that promote reduction in use, rather than complete elimination of use. A major challenge in promoting improvement is that, in order to catch true positive cases, we are willing to tolerate some overuse; the relevant question lies in what the optimal threshold is and where overuse becomes actionable. Adding to de-implementation challenges, that threshold may be different for different providers and in different situations—an “always right answer” likely does not exist. This challenge of balance and differences in risk tolerance can be a major challenge in de-implementation in general and for initatives focused on reducing clinical testing in particular. A second major challenge with blood culture collection and the downstream impacts on utilization and care is the high rate of false positives (eg, contamination) relative to true cases. Nearly 50% of positive blood cultures represent contaminants. Isolation of contaminants on blood cultures leads to increased length of stay, additional testing, and unnecessary antibiotic exposure and is also an independent target for improvement. Reference Dargère, Cormier and Verdon13

External factors, including national policy changes and supply chain challenges, can provide an opportunity to garner institutional support for diagnostic stewardship interventions. In July 2024, the FDA announced a shortage of BD BACTEC blood culture media bottles. Reference Food and Administration14 This shortage forced hospitals around the country to rapidly develop systems for improving their blood culture ordering practices, leading to successful reductions in inappropriate use that do not appear to have negatively impacted patient care. Following a rapid institutional multifaceted de-implementation intervention that leveraged this shortage and combined it with education and order restrictions, Humphries et al were able to decrease blood culture orders by 49%. Reference Humphries, Wright and Banerjee15

The external pressure from the shortage can be combined with other implementation/de-implementation strategies to create a bundle to support the de-implementation of excessive blood culture ordering and subsequent costly but unnecessary care (Figure 2). Political pressure leading to buy-in and prioritization for the project by facility leadership can be combined with provider education, including audit and feedback about practice patterns and recently developed guidelines for determining when blood cultures are indicated, and clinical decision support algorithms embedded into the EHR; this bundle of strategies has been found to successfully reduce the frequency of blood culture orders. Due to the general fear of litigation as a driver of both diagnostic testing and a barrier to de-implementation efforts, creation of standardized protocols by guideline-issuing bodies can also be a useful strategy to support change, as it provides a layer of protection for providers concerned that they are not providing the accepted standard of medical care. The general framework developed by Fabre et al in Clinical Infectious Diseases Reference Fabre, Sharara, Salinas, Carroll, Desai and Cosgrove16 provided a useful reference for providers concerned about limiting blood culture ordering; official endorsement and support from professional societies would provide an additional boost to de-implementation efforts in the direction of ordering less. Other effective strategies for de-implementing blood culture ordering include creation of local guidelines and policies, such as halting automatic blood culture orders prior to the insertion of a peripherally inserted central catheter in asymptomatic patients, and audit and feedback (with or without benchmarking). Reference Fabre, Carroll and Cosgrove17

Another focus to reduce the downstream consequences of unnecessary blood culture collection has been on optimizing the blood culture collection process, often through the use of diversion devices, to minimize contamination. Reference Al Mohajer and Lasco18 Although contamination devices do not reduce unnecessary blood culture ordering, by reducing contamination, they have the potential to reduce some of the downstream consequences of the practice that lead to subsequent low-value medical interventions and, in some cases, patient harm. Of note, both strategies can be combined to improve clinical care quality; one facility first implemented a diversion device and, in the setting of the national shortage, added a clinical decision support algorithm aimed at reducing the number of blood cultures ordered. Analysis is ongoing to see if this two-pronged approach was able to improve the yield of blood cultures while simultaneously reducing unnecessary treatment and follow-up testing stemming from a combination of excess use of blood cultures and subsequent identification of contaminants.

Asymptomatic bacteriuria

Asymptomatic bacteriuria has been a major stewardship target for the de-implementation of a low-value test (the urine culture) and preventing the administration of inappropriate antimicrobials. Common implementation/de-implementation strategies employed to reduce inappropriate urine culture collection and subsequent unnecessary treatment in asymptomatic patients include replacing urine culture orders with urinalysis with reflex to culture (eg, updating order sets and processes), removing urine culture orders from order sets, and reducing/restricting cultures performed by changing urinalysis with reflex to culture criteria. Ongoing audit and feedback via surveillance and reporting is another tool that can be employed to promote discontinuation, particularly if the review is occurring in near real-time. These de-implementation interventions, coupled with active implementation of other catheter-associated urinary tract infection (CAUTI) prevention measures, such as the “ABCs of ASB,” have resulted in significant reductions in urine culturing rates, antimicrobial use, and CAUTI rates. Reference Enriquez, Bouls, Alvarado and Maldonado19,Reference Gupta, Hartmann and Schweizer20 Additional interventions to reduce overuse of urine cultures (and resulting CAUTI diagnoses) include integration of soft (allowing clinician override) and hard stops (not allowing override) in the electronic medical record to prevent ordering. Demonstrating the positive impact of these de-implementation strategies, a quasi-experimental observational study involving 5 hospitals in Southeast Michigan found that the use of a hard stop to prevent inappropriate urine culturing led to a significant reduction in CAUTI rate and SIR. Reference Cherian, Tibbetts, Robinson, Holsey, Alangaden and Suleyman21

Clostridioides difficile diagnostics

Clostridioides difficile diagnostics, particularly PCR-based tests, are another important target for de-implementation, highlighted in the 2017 Update of the IDSA-SHEA Clinical Practice Guidelines for C. difficile infection (CDI). Reference Madden, Poulter and Sifri22 Initially, these assays offered improved turnaround time and reduced laboratory labor compared to culture and cytotoxicity assays, while reportedly maintaining high sensitivity. Reference Boly, Reske and Kwon23 However, the high sensitivity of these assays resulted in increased diagnosis of CDI and raised concern that positive results may represent colonization rather than active infection requiring treatment; furthermore, there were concerns that inappropriate treatment may be associated with unnecessary risk to patients. Reference Polage, Gyorke and Kennedy24,Reference Menon, Perry and Motyka25 Given these challenges, alternative strategies that mostly rely on multi-stepped processes (eg, confirmation of antigen testing, changing standard laboratory testing and contracts, changing hospital procedures to only allow samples with certain standards to be processed) have been employed to reduce reliance on PCR diagnostics. Additional effective efforts have focused on informational strategies, including educating providers about the use of laxatives if diarrhea develops and providing information about recent negative testing. Reference Rock, Abosi and Bleasdale27,Reference Calfee, Salgado and Milstone28

De-implementation in infection prevention

A common de-implementation intervention in infection prevention is the discontinuation of contact-based precautions for the prevention of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) transmission within a healthcare facility. Contact precautions were widely implemented as control measures to reduce transmission of VRE and MRSA and were considered a basic practice in the SHEA 2014 Update. Reference Calfee, Salgado and Milstone28 During the period since the 2014 guidance was published, alternative strategies for preventing these healthcare-associated infections (HAIs), such as decolonization protocols for MRSA, have emerged as more effective alternatives. Reference Huang29 Simultaneously, other studies have demonstrated patient harms and medical and industrial waste impacts associated with the widespread use of contact precautions and transmission of these pathogens has moved from being primarily hospital-focused to occurring in other settings, including household and community settings. Reference Di Ruscio, Guzzetta and Bjørnholt30,Reference Lee, OYong, LeBrun, Rubin and Miller31 As noted in the first part of this series, clinical medicine is practiced in the setting of constant change. Reference Branch-Elliman, Chambers and Albin1 This change drives the implementation and de-implementation life cycle of infection prevention initiatives, Reference Branch-Elliman, Chambers and Albin1 which must adapt as evidence, context, and environments change.

Given these ongoing changes and advancements, many facilities opted to move forward with de-implementing contact precautions, often leveraging a removal-and-replacement approach (eg, stopping contact precautions and implementing decolonization programs or enhanced hand hygiene programs). Reference Martin, Colaianne and Bridge32Reference Schrank, Snyder, Davis, Branch-Elliman and Wright34 Barriers to discontinuation of contact precautions can include provider perceptions about personal risk (eg, concern for personal safety and safety of the healthcare personnel’s family members), concern about liability (eg, concern about transmitting MRSA to another patient), existing order sets and facility protocols that reenforce and encourage the practice, and lack of knowledge about new, more effective interventions, among others. As evidence of the role risk and uncertainty play as major barriers to de-implementation initatives, special populations, among which perceived risks of stopping contact precautions are higher (eg, immunocompromised and pediatric populations), are slower to adopt change in the direction of doing less, with providers caring for these groups waiting for additional data to emerge about the “safety” of discontinuation of the practice. The slower change toward discontinuation in these higher-risk populations also highlights another perennial challenge in de-implementation efforts: once a baseline is established, it is quite hard in practice to take something away—even if the evidence supporting that baseline is weak, out of date, or non-existent. Evidence advancements and presentation of that evidence and education are implementation/deimplementation strategies that can be leveraged to support discontinuation but are almost never sufficient as stand-alone strategies to effect real practice change. Several of these identified barriers to discontinuation can be mapped to strategies (eg, ongoing evidence review and dissemination, education about risk, replacement with another more effective intervention, encouraging standard precautions, identification of champions, engagement and pressure from thought leaders) to support de-implementation efforts.

HAI surveillance activities are another example of an infection prevention program that can undergo substantial evolution and lead to positive change. One facility moved from local management of surveillance activities to a centralized program; in other words, this hospital network removed local reporting and replaced it with centralized reporting. Reference Snyder, Wagester and Harris35 Removing surveillance activities from local control freed up local infection prevention practitioners to spend more time on patient-facing activities, leading to perceived improvements in care delivery. Reference Snyder, Wagester and Harris35 In this case, although the surveillance program itself was sustained, the process and mechanism by which it was provided changed, and local surveillance activities were de-implemented in favor of other quality improvement activities. Reference Snyder, Wagester and Harris35

A final, and controversial, example in infection prevention and control is the use of universal masking policies in healthcare settings. Reference Klompas, Morris, Sinclair, Pearson and Shenoy36 Universal masking was implemented early in the pandemic when limited other options were able to prevent spread and to reduce disease severity. Reference Klompas, Morris and Shenoy37 However, after other tools became available, the downsides of the approach (interpersonal communication and connections, environmental waste, morale, difficulty with effective use and application) were increasingly apparent. Reference Martínez-Sellés, Sánchez and Guillén38,39 Given these changes, facilities across the country variably opted to change their policies about universal masking. Barriers to practice change included perceptions about risk both among patients and providers, political environment and beliefs creating external pressure both in favor of and opposing the policy, conflicting and uncertain evidence, and medical-legal concerns. Thought leaders and influencers in infection prevention also expressed different opinions about the policy, further complicating facility-level decisions about maintaining or de-implementing universal masking requirements. 39,Reference Kalu, Henderson, Weber and Haessler40 In the setting of these major barriers to de-implementation, some of the Expert Recommendations for Implementing Change (ERIC) implementation/de-implementation strategies, described in more detail in Part I, Reference Branch-Elliman, Chambers and Albin1,Reference Powell, Waltz and Chinman41 were used to support de-implementation efforts. These included communication with the public through editorials, op-eds, and television interviews, ongoing evidence reviews, educational sessions and listening sessions with colleagues, legal consultations, creations of communities of practice to share experiences and express views, and ongoing surveillance reporting to ensure stable outcomes after discontinuation of the practice. Some of these barriers and challenges may have been avoided had de-implementation plans been integrated into facility and public health responses upfront as part of a dynamic and adaptive process. Reference Branch-Elliman, Elwy and Chambers42 Integration of de-implementation and de-escalation should be considered an essential element of any future emergency response planning. In their piece on dynamic public health policy responses, Branch-Elliman et al. include a practical toolkit for dynamic policy responses that can be applied to support ongoing assessments of specific recommendations and if deimplementation is indicated. Reference Branch-Elliman, Elwy and Chambers42

As noted in an earlier example, and part of a recurring theme in de-implementation science, once a new baseline is established, resetting that baseline is extremely difficult—humans do not like having things taken away from them, no matter what the context. In healthcare settings—which inherently involve high-risk and high-emotion decisions—this tendency is amplified. Experience and data suggest that the burden of proof shifts toward demonstrating that a practice is ineffective or harmful, rather than the burden of proof resting on establishing that it is effective. Perhaps reflective of the ongoing controversies and disagreements about the evidence among thought leaders, not to mention the background political environment, many healthcare facilities follow local viral disease burden and risk stratification of patient populations (eg, neonates, bone marrow transplant) on when to initiate and de-implement masking during the respiratory season. Although the practice is common, as of this writing, an evidence-based risk threshold above which inpatient masking policies are effective has not been established.

In addition to the examples presented here, a summary of studies that have leveraged implementation and de-implementation principles in infection prevention is presented in Table 1. Though most reflect implementation, they are good examples of how the same theories, models, and frameworks can be used to support de-implementation efforts. For example, Schneider et al studied the implementation of a toolkit for prevention and control of carbapenem-resistant Enterobacteriaceae (CRE). Reference Schneider, Coope, Michie, Puleston, Hopkins and Oliver43 The purpose of the UK CRE toolkit was to empower frontline staff and leadership with information and to recommend process changes. Reference Stokle, Johnson and Woodford44 The CRE toolkit was designed to have strategies to support rapid implementation efforts, but many of the strategies, such as communications strategies, could also be leveraged to support de-implementation efforts once the perceived risk period has elapsed. Ironically, Schneider et al reported that a major limitation of the toolkit was that potential users found that the recommendations and strategies included in the toolkit were impractical (failing the feasibility test) and a lack of trust in the level of evidence included in the recommendations (failing the acceptability test). Reference Schneider, Coope, Michie, Puleston, Hopkins and Oliver43 Additional concerns included uncertainty about risk as well as receiving too much and overly detailed information. Reference Schneider, Coope, Michie, Puleston, Hopkins and Oliver43

Table 1. Practical examples of de-implementation science in infection prevention

Note. TMFs, theories, models, and frameworks; RE-AIM, reach, effectiveness, adoption, implementation, maintenance; COM-B, capabilities, opportunities, and motivation to perform a behavior; i-PARiHS, integrated promoting action on research implementation in health services.

Antimicrobial stewardship

Discontinuation of low-value interventions is a core responsibility of stewardship programs; in fact, a systematic review found that reducing unnecessary antimicrobial use is one of the most frequently studied applications of de-implementation investigations. Reference Kien, Daxenbichler and Titscher49 Diagnostic stewardship interventions, as discussed above, are increasingly emerging as an effective strategy for promoting antimicrobial stewardship goals and de-implementing ineffective antimicrobial use in patients with colonization rather than active infection. Reference Rico, Sulaiman and MacLeod50Reference Advani, Polage and Fakih52

Surgical prophylaxis: times change

The Surgical Care Improvement Project (SCIP) was a national quality improvement campaign designed to promote improvements in perioperative care; among the original elements of the SCIP was a recommendation associated with mandated public reporting to discontinue antimicrobials within 24 hours of surgery and within 48 hours for cardiac surgery. Reference Branch-Elliman, Elwy and Lamkin53,Reference Branch-Elliman, Golenbock and Hederstedt54 To achieve compliance with these reporting requirements, facilities adopted a variety of strategies, including order sets, educational programs, and audit and feedback, among others. The antimicrobial use reporting requirement was sunsetted in 2015. During the period since the program ended, guidelines evolved to recommend immediate discontinuation of antimicrobials after surgery rather than permitting post-operative administration. Reference Calderwood, Anderson and Bratzler55 However, processes and physician educational interventions from the original SCIP program, such as order sets embedded into the EHR, remain. Reference Branch-Elliman, Elwy and Lamkin53,Reference Pendergast, Mull and Shin56 Thus, there is a need for additional de-implementation efforts to support the adoption of the new recommendations. Factors that may continue to support the ongoing application of older guidelines include provider concerns about providing sub-standard care (eg, medical-legal concerns), embedded processes that support ongoing use (eg, standardized order sets), and knowledge and understanding about current recommendations. Reference Pendergast, Mull and Shin56 These barriers to change suggest several strategies for promoting de-implementation initiatives, including engagement of IT services to update order sets, educational campaigns, and audit and feedback with benchmarking to demonstrate to providers that discontinuation is within the acceptable standard of care. Support from key, trusted opinion leaders and local experts about the safety of the practice change can also help to provide reassurance to those who are uncomfortable with the immediate discontinuation of prophylaxis.

Dental prophylaxis

Estimates suggest that up to 10% of all antimicrobial use occurs in dental offices; the vast majority of this use is either inappropriate or frankly contraindicated. Reference Suda, Calip and Zhou57,Reference Suda, Fitzpatrick and Gibson58 Reasons for high rates of use in dental settings include lack of knowledge about guidelines, concerns about severe adverse events and medical liability (eg, failure to provide prophylaxis will cause endocarditis), and limited feedback about harms of the treatment. These drivers of practice imply several strategies to support de-implementation initiatives: provider education, improved engagement and linkage to key thought leaders and experts, and better systems of providing feedback about use, current standards of care, and harms of the treatment. Unlike the inpatient setting where these strategies may be more easily deployed, a major challenge in the dental setting is the disconnected, diffuse nature of dental practices and limited linkage to experts who can support the de-implementation efforts. Ongoing studies seek to identify ways to overcome these challenges to improve care. Reference Branch-Elliman, Lamkin and Shin59

Additional examples of implementation and de-implementation science leading to changes in behaviors and processes in antimicrobial stewardship are presented in Table 2.

Table 2. Practical examples of de-implementation science in antimicrobial stewardship

Note. TMFs, theories, models, and frameworks; RE-AIM, reach, effectiveness, adoption, implementation, maintenance; COM-B, capabilities, opportunities, and motivation to perform a behavior; i-PARiHS, integrated promoting action on research implementation in health services.

Conclusions

De-implementation is an inherent part of a program’s life cycle. As evidence evolves and conditions and context change, infection prevention and stewardship programs need to adapt to the new environment. Barriers to practice change in the direction doing less can differ from those for implementation initatives. They tend to be more influenced by risk aversion, uncertainty, and a general bias toward supporting the status quo relative to “do more” barriers. Medicine and public health have a strong action bias—but sometimes, the best medicine dictates we do less, not more. Leveraging principles of de-implementation science can help move us in the right direction.

Acknowledgments

The authors would like to thank David Chambers, DPhil, for his critical review of the manuscript, feedback about the contents, and overall support. Many of the ideas and concepts presented are extensions of his work and reflect his remarkable and impactful contributions to the field of implementation science, de-implementation science, and sustainability in healthcare.

Financial support

This study was unfunded. WBE is supported by VA HSR IIR 20-076 and VA HSR IIR 20-101.

Competing interests

None.

References

Branch-Elliman, W, Chambers, DA, Albin, O, et al. The life cycle of infection prevention and antimicrobial stewardship projects and interventions: the dynamic interplay of implementation and de-implementation science (Part I of II). Infect Control Hosp Epidemiol 2025:12.Google Scholar
Norton, WE, Chambers, DA. Unpacking the complexities of de-implementing inappropriate health interventions. Implement Sci 2020;15:2. doi: 10.1186/s13012-019-0960-9 CrossRefGoogle ScholarPubMed
Norton, WE, Kennedy, AE, Chambers, DA. Studying de-implementation in health: an analysis of funded research grants. Implement Sci 2017;12:144. doi: 10.1186/s13012-017-0655-z CrossRefGoogle ScholarPubMed
Powell, BJ, Beidas, RS, Lewis, CC, et al. Methods to improve the selection and tailoring of implementation strategies. J Behav Health Serv Res 2017;44(2):177194. doi: 10.1007/s11414-015-9475-6 CrossRefGoogle ScholarPubMed
Powell, BJ, Waltz, TJ, Chinman, MJ, et al. A refined compilation of implementation strategies: results from the expert recommendations for implementing change (ERIC) project. Implement Sci 2015;10:21. doi: 10.1186/s13012-015-0209-1 CrossRefGoogle ScholarPubMed
Proctor, EK, Powell, BJ, McMillen, JC. Implementation strategies: recommendations for specifying and reporting. Implement Sci 2013;8:139. doi: 10.1186/1748-5908-8-139 CrossRefGoogle ScholarPubMed
Waltz, TJ, Powell, BJ, Fernández, ME, Abadie, B, Damschroder, LJ. Choosing implementation strategies to address contextual barriers: diversity in recommendations and future directions. Implement Sci 2019;14:42. doi: 10.1186/s13012-019-0892-4 CrossRefGoogle ScholarPubMed
Eva, WV, Simone, AvD, Gert, PW, et al. Reducing low-value care: what can we learn from eight de-implementation studies in the Netherlands? BMJ Open Qual 2022;11:e001710. doi: 10.1136/bmjoq-2021-001710 Google Scholar
Morgan, DJ, Malani, P, Diekema, DJ. Diagnostic stewardship—leveraging the laboratory to improve antimicrobial use. JAMA 2017;318:607608. doi: 10.1001/jama.2017.8531 CrossRefGoogle ScholarPubMed
Morgan, DJ, Pineles, L, Owczarzak, J, et al. Accuracy of practitioner estimates of probability of diagnosis before and after testing. JAMA Intern Med 2021;181:747755. doi: 10.1001/jamainternmed.2021.0269 CrossRefGoogle ScholarPubMed
Grace, CJ, Lieberman, J, Pierce, K, Littenberg, B. Usefulness of blood culture for hospitalized patients who are receiving antibiotic therapy. Clin Infect Dis 2001;32:16511655. doi: 10.1086/320527 CrossRefGoogle ScholarPubMed
Wilson, ML. Clinically relevant, cost-effective clinical microbiology: strategies to decrease unnecessary testing. Am J Clin Pathology 1997;107:154167.CrossRefGoogle ScholarPubMed
Dargère, S, Cormier, H, Verdon, R. Contaminants in blood cultures: importance, implications, interpretation and prevention. Clin Microb Infect 2018;24:964969.CrossRefGoogle ScholarPubMed
Food, U, Administration, D. Disruptions in Availability of BD BACTEC Blood Culture Media Bottles-Letter to Health Care Providers. 2024.Google Scholar
Humphries, RM, Wright, PW, Banerjee, R, et al. Rapid implementation of blood culture stewardship: institutional response to an acute national blood culture bottle shortage. Clinical Infectious Diseases 2024:ciae402.10.1093/cid/ciae402CrossRefGoogle Scholar
Fabre, V, Sharara, SL, Salinas, AB, Carroll, KC, Desai, S, Cosgrove, SE. Does this patient need blood cultures? A scoping review of indications for blood cultures in adult nonneutropenic inpatients. Clin Infect Dis 2020;71:13391347.CrossRefGoogle ScholarPubMed
Fabre, V, Carroll, KC, Cosgrove, SE. Blood culture utilization in the hospital setting: a call for diagnostic stewardship. J Clin Microb 2022;60:e0100521.10.1128/jcm.01005-21CrossRefGoogle Scholar
Al Mohajer, M, Lasco, T. The impact of initial specimen diversion systems on blood culture contamination. Oxford University Press US; 2023:ofad182.CrossRefGoogle Scholar
Enriquez, PV, Bouls, R, Alvarado, EW, Maldonado, JC. 1272. Teaching the ABCs of ASB in a 60-minute educational intervention. A quality improvement project. Oxford University Press US; 2023:ofad500. 1112.CrossRefGoogle Scholar
Gupta, K, Hartmann, C, Schweizer, ML. 1053. De-Implementing Low-Value Antibiotic Prescribing Across Levels of Care. 2019:10.1093/ofid/ofz360.917CrossRefGoogle Scholar
Cherian, J, Tibbetts, R, Robinson, P, Holsey, T, Alangaden, GJ, Suleyman, G. 2031. Role of Urine Culture Hard Stop in Reducing Catheter-associated Urinary Tract Infections. Oxford University Press US; 2022:ofac492. 1654.10.1093/ofid/ofac492.1654CrossRefGoogle Scholar
Madden, GR, Poulter, MD, Sifri, CD. Diagnostic stewardship and the 2017 update of the IDSA-SHEA clinical practice guidelines for Clostridium difficile infection. Diagnosis 2018;5:119125.CrossRefGoogle ScholarPubMed
Boly, FJ, Reske, KA, Kwon, JH. The role of diagnostic stewardship in Clostridioides difficile testing: challenges and opportunities. Curr Infect Dis Rep 2020;22:112.CrossRefGoogle ScholarPubMed
Polage, CR, Gyorke, CE, Kennedy, MA, et al. Overdiagnosis of Clostridium difficile infection in the molecular test era. JAMA Internal Med 2015;175:17921801.10.1001/jamainternmed.2015.4114CrossRefGoogle ScholarPubMed
Menon, A, Perry, DA, Motyka, J, et al. Changes in the association between diagnostic testing method, polymerase chain reaction Ribotype, and clinical outcomes from Clostridioides difficile infection: one institution’s experience. Clin Infect Dis 2021;73:e2883e2889.CrossRefGoogle ScholarPubMed
Krouss, M, Israilov, S, Alaiev, D, et al. SEE the DIFFerence: reducing unnecessary C. difficile orders through clinical decision support in a large, urban safety-net system. Am J Infect Control 2023;51:786791.CrossRefGoogle Scholar
Rock, C, Abosi, O, Bleasdale, S, et al. Clinical decision support systems to reduce unnecessary Clostridioides difficile testing across multiple hospitals. Clin Infect Dis 2022;75:11871193.10.1093/cid/ciac074CrossRefGoogle ScholarPubMed
Calfee, DP, Salgado, CD, Milstone, AM, et al. Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014;35:S108S132.CrossRefGoogle ScholarPubMed
Huang, S. Chlorhexidine-based decolonization to reduce healthcare-associated infections and multidrug-resistant organisms (MDROs): who, what, where, when, and why? J Hosp Infect 2019;103:235243.CrossRefGoogle Scholar
Di Ruscio, F, Guzzetta, G, Bjørnholt, JV, et al. Quantifying the transmission dynamics of MRSA in the community and healthcare settings in a low-prevalence country. Proc. Natl Acad Sci USA 2019;116(29):1459914605. doi: 10.1073/pnas.1900959116.CrossRefGoogle Scholar
Lee, P, OYong, K, LeBrun, M, Rubin, ZA, Miller, LG. P-335. Environmental Impact of Contact Precaution Use for Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococcus (VRE) in Los Angeles (LA) County: Results of a Countywide Survey. Open Forum Infect Dis 2025;12(Supplement_1):ofae631.538. doi: 10.1093/ofid/ofae631.538.CrossRefGoogle Scholar
Martin, EM, Colaianne, B, Bridge, C, et al. Discontinuing MRSA and VRE contact precautions: defining hospital characteristics and infection prevention practices predicting safe de-escalation. Infect Control Hosp Epidemiol 2022;43:15951602.CrossRefGoogle ScholarPubMed
Karunakaran, S, Pless, L, Ayres, A, et al. Impact of discontinuation of contact precautions on surveillance- and whole-genome sequencing-defined MRSA infections. Antimicrob Steward Healthc Epidemiol 2023;3:s13s14.10.1017/ash.2023.227CrossRefGoogle Scholar
Schrank, GM, Snyder, GM, Davis, RB, Branch-Elliman, W, Wright, SB. The discontinuation of contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: impact upon patient adverse events and hospital operations. BMJ Qual Saf 2020;29:12.10.1136/bmjqs-2018-008926CrossRefGoogle ScholarPubMed
Snyder, GM, Wagester, S, Harris, PL, et al. Development and implementation of a centralized surveillance infection prevention program in a multi-facility health system: A quality improvement project. Antimicrob Steward Healthc Epidemiol 2023;3:e56.10.1017/ash.2023.126CrossRefGoogle Scholar
Klompas, M, Morris, CA, Sinclair, J, Pearson, M, Shenoy, ES. Universal masking in hospitals in the Covid-19 era. New England J Med 2020;382:e63.CrossRefGoogle ScholarPubMed
Klompas, M, Morris, CA, Shenoy, ES. Universal masking in the Covid-19 era. New England J Med 2020;383:e9.CrossRefGoogle ScholarPubMed
Martínez-Sellés, M, Sánchez, FJM, Guillén, SM, et al. Advantages and disadvantages of maintaining the mandatory use of masks in health centers and nursing homes in Spain. How and when is it justified to maintain it? Rev Es Quimioter 2023;36:466.CrossRefGoogle Scholar
Universal Masking in Health Care Settings: A Pandemic Strategy Whose Time Has Come and Gone, For Now. Annals of Internal Medicine. 2023;176:859861. doi: 10.7326/m23-0793 %m 37068281CrossRefGoogle Scholar
Kalu, IC, Henderson, DK, Weber, DJ, Haessler, S. Back to the future: redefining “universal precautions” to include masking for all patient encounters. Infect Control Hosp Epidemiol 2023;44:13731374.CrossRefGoogle Scholar
Powell, BJ, Waltz, TJ, Chinman, MJ, et al. A refined compilation of implementation strategies: results from the expert recommendations for implementing change (ERIC) project. Implement Sci 2015;10:114.CrossRefGoogle ScholarPubMed
Branch-Elliman, W, Elwy, AR, Chambers, DA. Embracing dynamic public health policy impacts in infectious diseases responses: leveraging implementation science to improve practice. Front Public Health 2023;11:1207679.10.3389/fpubh.2023.1207679CrossRefGoogle ScholarPubMed
Schneider, A, Coope, C, Michie, S, Puleston, R, Hopkins, S, Oliver, I. Implementing a toolkit for the prevention, management and control of carbapenemase-producing Enterobacteriaceae in English acute hospitals trusts: a qualitative evaluation. BMC Health Serv Res 2019;19:120.CrossRefGoogle ScholarPubMed
Stokle, L, Johnson, A, Woodford, N. Acute trust toolkit for the early detection, management and control of carbapenemase-producing Enterobacteriaceae. 2013.Google Scholar
Dekker, M, Jongerden, IP, Caris, MG, de Bruijne, MC, Vandenbroucke-Grauls, CM, van Mansfeld, R. Evaluation of an infection control link nurse program: an analysis using the RE-AIM framework. BMC Health Serv Res 2023;23:140.CrossRefGoogle ScholarPubMed
Kallam, B, Pettitt-Schieber, C, Owen, M, Agyare Asante, R, Darko, E, Ramaswamy, R. Implementation science in low-resource settings: using the interactive systems framework to improve hand hygiene in a tertiary hospital in Ghana. Int J Qual Health Care 2018;30:724730.CrossRefGoogle Scholar
Hall, L, White, NM, Allen, M, et al. Effectiveness of a structured, framework-based approach to implementation: the researching effective approaches to cleaning in hospitals (REACH) Trial. Antimicrob Resist Infect Cont 2020;9:19.Google ScholarPubMed
Balbale, SN, Hill, JN, Guihan, M, et al. Evaluating implementation of methicillin-resistant Staphylococcus aureus (MRSA) prevention guidelines in spinal cord injury centers using the PARIHS framework: a mixed methods study. Implement Sci 2015;10:115.CrossRefGoogle ScholarPubMed
Kien, C, Daxenbichler, J, Titscher, V, et al. Effectiveness of de-implementation of low-value healthcare practices: an overview of systematic reviews. Implement Sci 2024;19:56.10.1186/s13012-024-01384-6CrossRefGoogle ScholarPubMed
Rico, M, Sulaiman, R, MacLeod, R. Asymptomatic bacteriuria: impact of an antimicrobial stewardship bundle to reduce unnecessary antibiotics in patients without urinary catheters. Am J Health-Syst Pharm 2021;78:S83S87.10.1093/ajhp/zxab220CrossRefGoogle ScholarPubMed
Gupta, K, O’Brien, W, Gallegos-Salazar, J, Strymish, J, Branch-Elliman, W. How testing drives treatment in asymptomatic patients: level of pyuria directly predicts probability of antimicrobial prescribing. Clin Infect Dis 2020;71:614621.10.1093/cid/ciz861CrossRefGoogle ScholarPubMed
Advani, SD, Polage, CR, Fakih, MG. Deconstructing the urinalysis: a novel approach to diagnostic and antimicrobial stewardship. Antimicrob Steward Healthc Epidemiol 2021;1:e6.10.1017/ash.2021.167CrossRefGoogle ScholarPubMed
Branch-Elliman, W, Elwy, AR, Lamkin, RL, et al. Assessing the sustainability of compliance with surgical site infection prophylaxis after discontinuation of mandatory active reporting: study protocol. Implement Sci Communica 2022;3:47.10.1186/s43058-022-00288-0CrossRefGoogle ScholarPubMed
Branch-Elliman, W, Golenbock, S, Hederstedt, K, et al. 1233. Leveraging informatics to evaluate and sustain improvements in peri-operative antimicrobial prophylaxis achieved under the surgical care improvement project (SCIP). Open Forum Infect Dis 2023;10. doi: 10.1093/ofid/ofad500.1073.CrossRefGoogle Scholar
Calderwood, MS, Anderson, DJ, Bratzler, DW, et al. Strategies to prevent surgical site infections in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol 2023;44:695720.CrossRefGoogle ScholarPubMed
Pendergast, J, Mull, H, Shin, M, et al. Sustainability and spread of best practices for peri-operative antimicrobial stewardship following discontinuation of mandatory public reporting: perceptions from the Society for Healthcare Epidemiology in America research network. Infect Control Hosp Epidemiol. 2025:16. doi: 10.1017/ice.2025.61.Google Scholar
Suda, KJ, Calip, GS, Zhou, J, et al. Assessment of the appropriateness of antibiotic prescriptions for infection prophylaxis before dental procedures, 2011 to 2015. JAMA Netw Open 2019;2:e193909–e193909.10.1001/jamanetworkopen.2019.3909CrossRefGoogle ScholarPubMed
Suda, KJ, Fitzpatrick, MA, Gibson, G, et al. Antibiotic prophylaxis prescriptions prior to dental visits in the veterans’ health administration (VHA), 2015–2019. Infect Cont Hosp Epidemiol 2022;43:15651574.CrossRefGoogle ScholarPubMed
Branch-Elliman, W, Lamkin, R, Shin, M, et al. Promoting de-implementation of inappropriate antimicrobial use in cardiac device procedures by expanding audit and feedback: protocol for hybrid III type effectiveness/implementation quasi-experimental study. Implement Sci 2022;17:12.10.1186/s13012-022-01186-8CrossRefGoogle ScholarPubMed
Malone, S, McKay, VR, Krucylak, C, et al. A cluster randomized stepped-wedge trial to de-implement unnecessary post-operative antibiotics in children: the optimizing perioperative antibiotic in children (OPerAtiC) trial. Implement Sci 2021;16:111.CrossRefGoogle ScholarPubMed
McDaniel, CE, Kerns, E, Jennings, B, et al. Improving guideline-concordant care for febrile infants through a quality improvement initiative. Pediatrics 2024;153:e2023063339.10.1542/peds.2023-063339CrossRefGoogle ScholarPubMed
Haskell, L, Tavender, EJ, Wilson, CL, et al. Development of targeted, theory-informed interventions to improve bronchiolitis management. BMC Health Serv Res 2021;21:113.CrossRefGoogle ScholarPubMed
Haskell, L, Tavender, EJ, Wilson, CL, et al. Effectiveness of targeted interventions on treatment of infants with bronchiolitis: a randomized clinical trial. JAMA Pediatr 2021;175:797806.10.1001/jamapediatrics.2021.0295CrossRefGoogle ScholarPubMed
Livorsi, DJ, Sherlock, SH, Goedken, CC, et al. The use of telehealth-supported stewardship activities in acute-care and long-term care settings: an implementation effectiveness trial. Infect Control Hosp Epidemiol 2023;44:20282035.10.1017/ice.2023.81CrossRefGoogle ScholarPubMed
Figure 0

Figure 1. Practical application of de-implementation science principles to support effective removal of low-value care.

Figure 1

Figure 2. De-implementation mapping process applied to reducing unnecessary blood culture orders.

Figure 2

Table 1. Practical examples of de-implementation science in infection prevention

Figure 3

Table 2. Practical examples of de-implementation science in antimicrobial stewardship